Technique uses 3-D weaving to grow a living hip replacement
With a goal of treating worn, arthritic hips without extensive surgery to replace them, scientists have programmed stem cells to grow new cartilage on a 3-D template shaped like the ball of a hip joint. What’s more, using gene therapy, they have activated the new cartilage to release anti-inflammatory molecules to fend off a return of arthritis.
The technique, demonstrated in a collaborative effort between Washington University School of Medicine in St. Louis and Cytex Therapeutics Inc. in Durham, N.C., is described July 18 in Proceedings of the National Academy of Sciences.
The discovery one day may provide an alternative to hip-replacement surgery, particularly in younger patients. Doctors are reluctant to perform such operations in patients under age 50 because prosthetic joints typically last for less than 20 years. A second joint-replacement surgery to remove a worn prosthetic can destroy bone and put patients at risk for infection.
“Replacing a failed prosthetic joint is a difficult surgery,” said Farshid Guilak, PhD, a professor of orthopedic surgery at Washington University. “We’ve developed a way to resurface an arthritic joint using a patient’s own stem cells to grow new cartilage, combined with gene therapy to release anti-inflammatory molecules to keep arthritis at bay. Our hope is to prevent, or at least delay, a standard metal and plastic prosthetic joint replacement.”
The technique uses a 3-D, biodegradable synthetic scaffold that Guilak and his team developed. The scaffold, molded into the precise shape of a patient’s joint, is covered with cartilage made from the patient’s own stem cells taken from fat beneath the skin. The scaffold then can be implanted onto the surface of an arthritic hip, for example. Resurfacing the hip joint with “living” tissue is designed to ease arthritis pain, and delay or even eliminate the need for joint-replacement surgery in some patients.
Additionally, by inserting a gene into the newly grown cartilage and activating it with a drug, the gene can orchestrate the release of anti-inflammatory molecules to fight a return of arthritis, which usually is what triggers such joint problems in the first place.
“When there is inflammation, we can give a patient a simple drug, which activates the gene we’ve implanted, to lower inflammation in the joint,” said Guilak, also a professor of developmental biology and of biomedical engineering. “We can stop giving the drug at any time, which turns off the gene.”
That gene therapy is important, he explained, because when levels of inflammatory molecules rise in a joint, the cartilage is destroyed and pain increases. By adding gene therapy to the stem cell and scaffold technique, Guilak and his colleagues believe it will be possible to coax patients’ joints to fend off arthritis and function better for a longer time.
The 3-D scaffold is built using a weaving pattern that gives the device the structure and properties of normal cartilage. Franklin Moutos, PhD, vice president of technology development at Cytex, explained that the unique structure is the result of approximately 600 biodegradable fiber bundles woven together to create a high-performance fabric that can function like normal cartilage.
“As evidence of this, the woven implants are strong enough to withstand loads up to 10 times a patient’s body weight, which is typically what our joints must bear when we exercise,” Moutos said.
Currently, there are about 30 million Americans who have diagnoses of osteoarthritis, and data suggest that the incidence of osteoarthritis is on the rise. That number includes many younger patients — ages 40 to 65 — who have limited treatment options because conservative approaches haven’t worked and they are not yet candidates for total joint replacement because of their ages.
Bradley Estes, PhD, vice president of research and development at Cytex, noted, “We envision in the future that this population of younger patients may be ideal candidates for this type of biological joint replacement.”
Guilak, who also is the director of research at Shriners Hospitals for Children — St. Louis, and co-director of the Washington University Center of Regenerative Medicine, has been collaborating with Cytex on this research. The scientists have tested various aspects of the tissue engineering in cell culture, and some customized implants already are being tested in laboratory animals. He said if all goes well, such devices could be ready for safety testing in humans in three to five years.
The Latest on: Stem cells to grow new cartilage
via Google News
The Latest on: Stem cells to grow new cartilage
- Cartilage Repair/ Cartilage Regeneration Market worth $1,603 million by 2025 - Exclusive Report by MarketsandMarkets™on October 9, 2020 at 7:34 am
In 2019, the cell-based segment accounted for the largest share of the cartilage regeneration market. The large share of this segment can be attributed to technological advancements in stem cell-based ...
- Cartilage Repair/ Cartilage Regeneration Market worth $1,603 million by 2025 - Exclusive Report by MarketsandMarketson October 9, 2020 at 7:34 am
According to the new market research report "Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities (Cell based Type (Chondrocyte Transplantation ...
- Stem cell treatment for damaged kneeson October 9, 2020 at 6:21 am
Stem cell research has achieved some promising results in preventing or delaying the onset of osteoarthritis in younger people who have damaged their knees through sport or trauma.
- Stem cells repair damaged circuits in mice with Parkinson’son September 30, 2020 at 1:50 pm
New research finds that stem cell therapy led to motor skill improvement after 4–5 months in mice with Parkinson's disease.
- Transplants of stem-cell-grown neurons repair Parkinson's damage in miceon September 28, 2020 at 5:00 pm
Stem cells are a promising experimental treatment for a variety of diseases. Now researchers at the University of Wisconsin-Madison have found that transplanting neurons grown from stem cells into the ...
- 3-D bioprinting constructs for cartilage regenerationon September 23, 2020 at 6:33 am
However, it is challenging to develop large-scale biomimetic anisotropic constructs that structurally mimic native cartilage. In a new report ... mesenchymal stem cell (MSC)-laden hydrogels ...
- Regrowing knee cartilage: new animal studies show promiseon September 16, 2020 at 11:08 am
There are other methods that have been developed to make new cartilage from cartilage cells or stem cells, but they involve taking the stem cells out of the patients’ knees, growing and treating ...
- Future of curing knee pain? Stanford study finds solution involving creating new cartilageon September 10, 2020 at 4:44 pm
(KGO) -- If you suffer from joint pain, a new study ... that skeletal stem cells in bone actually have the ability to grow different materials, including bone, spongy bone, scar-cartilage, and ...
- Cell Therapy for Strokeon September 10, 2020 at 7:49 am
Cell therapy always appeared an unlikely strategy for stroke. Cell therapy was conceived as a means for tissue replacement. If tissue were lost through injury or disease, then new cells ...
- Grow neck vertebrae from adult stem cellson September 6, 2020 at 4:59 pm
UC DAVIS (US) — Neurosurgeons are using a new stem cell therapy to promote the growth ... where the cushioning cartilage has worn away, leaving bone to rub against bone, and herniated discs ...
via Bing News